상단으로 가기
컨텐츠 바로가기

GLOBAL MARKET
Hana Pharm is moving forward to a global market

HOME Research & Development Global Business

Global Business

We are expanding global presence
and strengthening partnerships
with the global companies.

We export finished products and API to the Southeast Asian countries and Japan leveraging our decades of expertise in drug development and manufacturing of highly qualified pharmaceuticals.

Inquiry on global business
  • We have established a solid position in the overseas market with our well-balanced and rich pipeline as narcotics and anesthetics specialty company in S. Korea.

    • Sevofran Liquid for Inhalation (Sevoflurane)
    • Ifran Liquid for Inhalation (Isoflurane)
    • Anepol Injection (Propofol)
    • Vascam Injection (Midazolam)
    • Hana Nalbuphine HCI Injection (Nalbuphine HCI)
    • Atra Injection (Atracurium Besylate)
    • Betasin Injection (Labetalol HCI)
  • Based on continuous research and excellent productivity, we sell our synthetic drug substances to well-known domestic and overseas pharmaceutical companies, mainly in the Japanese market.

    • Bepotastine besilate
    • Granisetron HCI
    • Ramosetron HCI
    • Aprepitant
    • Cinacalcet HCI
    • Palonosetron HCI
    • Dexmedetomidine
    • Rivaroxaban
    • Azilsartan
    • Azelastine HCI